Virology News and Research

Latest Virology News and Research

Influenza pandemic policies: WHO denies being improperly influenced by pharmaceutical industry

Providing independent advice to Member States is a very important function of the World Health Organization (WHO). We take this work seriously and guard against the influence of any improper interests. The WHO influenza pandemic policies and response have not been improperly influenced by the pharmaceutical industry.

20 Mar 2010

Effective defense against HIV: Acne drug minocycline

Johns Hopkins scientists have found that a safe and inexpensive antibiotic in use since the 1970s for treating acne effectively targets infected immune cells in which HIV, the virus that causes AIDS, lies dormant and prevents them from reactivating and replicating.

20 Mar 2010

National Native HIV/AIDS Awareness Day: NIAID Director issues statement

Following is a statement of Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases National Institutes of Health on National Native HIV/AIDS Awareness Day, March 20, 2010:

19 Mar 2010

Pressure BioSciences announces presentations on advantages of PCT

Pressure BioSciences, Inc. today announced that five presentations on the advantages of pressure cycling technology (PCT) in the preparation, processing, identification, and quantification of proteins were made at last week's annual meeting of US HUPO (Human Proteomics Organization) in Denver, Colorado.

From Thermo Fisher Scientific Inc. 19 Mar 2010

Activeion Cleaning Solutions announces new European subsidiary, Activeion GmbH

Activeion Cleaning Solutions LLC, Rogers, MN USA is proud to announce its new European subsidiary, Activeion (Europe) GmbH. Activeion (Europe) GmbH will distribute and market the ionator EXP™ throughout Europe, the Middle East and Africa. Activeion's ionator EXP™ is a handheld, on-demand, completely chemical-free cleaning tool that activates and converts tap water into ionised water, a powerful dirt-removing and bacteria-killing product.

19 Mar 2010

FDA categorizes Nanosphere's RVNATSP assay on Verigene SP System as "Moderate Complexity"

Nanosphere, Inc., a leader in the development and commercialization of advanced molecular diagnostics systems, received notification from the U.S. Food and Drug Administration (FDA) that its respiratory virus panel (RVNATSP) performed on the Verigene SP System has been categorized as "Moderate Complexity" under the Clinical Laboratory Improvement Amendments of 1988 (CLIA).

19 Mar 2010

Researchers use optogenetics technology to troubleshoot neural circuits

Recently, brain researchers have gained a powerful new way to troubleshoot neural circuits associated with depression, Parkinson's disease and other conditions in small animals such as rats. They use an optogenetics technology, invented at Stanford University, that precisely turns select brain cells on or off with flashes of light. Although useful, the optogenetics tool set has been limited.

19 Mar 2010

Scientists synthesize multifunctional polymer that can decontaminate biological and chemical toxins

In an ongoing effort to mirror the ability of biological tissues to respond rapidly and appropriately to changing environments, scientists from the McGowan Institute for Regenerative Medicine have synthesized a single, multifunctional polymer material that can decontaminate both biological and chemical toxins. They described the findings recently in Biomaterials.

19 Mar 2010

Norgen Biotek launches over 30 new kits for NA based diagnostics

Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acids (NA) and protein purification, today announced the launch of over 30 new kits for nucleic-acid based diagnostics. Norgen makes best-in-class kits for nucleic acid and protein sample preparation, and has recognized that high quality sample preparation is the key to high quality diagnostics.

19 Mar 2010

Three scientists receive 2010 Discoverers Award for developing new class of HIV drug

Three scientists who led the 11-year quest to develop a groundbreaking HIV drug today received the 2010 Discoverers Award -- the highest honor given to scientists by the Pharmaceutical Research and Manufacturers of America. The honorees are Tony Wood, Ph.D., Elna van der Ryst, M.D., Ph.D. and Manos Perros, Ph.D.

19 Mar 2010

Acne drug prevents HIV breakout

18 Mar 2010

Yellow fever outbreak in howler monkeys signals the need for human vaccination program

A group of Argentine scientists, including health experts from the Wildlife Conservation Society, have announced that yellow fever is the culprit in a 2007-2008 die-off of howler monkeys in northeastern Argentina, a finding that underscores the importance of paying attention to the health of wildlife and how the health of people and wild nature are so closely linked.

18 Mar 2010

Modulating body's inflammatory response may help fight serious infection

Treating virulent influenza, sepsis, and other potentially deadly infections long has focused on looking for ways to kill viruses and bacteria. But new research from the University of Utah and Utah State University shows that modulating the body's own overeager inflammatory response to infection may help save more lives.

18 Mar 2010

MediCare International offers insurance for all nationalities

The Lebanon is an important centre for international workers - Post conflict international health cover hard to arrange - Good hospital facilities can only be accessed with the right cover - MediCare International offers insurance for all nationalities

18 Mar 2010

Scientists discover switch mechanism that controls cells' trafficking system

Scientists have identified a mechanism that switches on an extremely important process for the proper functioning and survival of our body's cells. Specifically, the fast-track transportation pathway of 'cargo' to and from the surface of the cell.

18 Mar 2010

CytoDyn commences full humanization of Cytolin immune therapy for treating HIV/AIDS

CytoDyn, Inc. has begun full humanization of Cytolin®, the Company’s unique immune therapy for treating HIV/AIDS. Although a murine (mouse) version of Cytolin® was used for previous human experience that included some 200 patients successfully treated for up to two years, as well as an encouraging Phase I(b)/II(a) study, the Company believes that a fully-humanized version is necessary for the clinical trial that is expected to follow the current one (described at http://clinicaltrials.gov) for the reasons explained below.

17 Mar 2010

ICID provides online planning tools to help non-profit organizations develop pandemic flu plans

On the heels of the recent H1N1 pandemic, the International Centre for Infectious Diseases is providing online planning tools to help non-profit organizations develop pandemic flu plans. It is urging vigilance against future waves of the virus, and advises organizations to take action now to plan for events that could threaten the delivery of service to their clients.

17 Mar 2010

China Sky One Medical's 2009 fourth-quarter total revenues up 15.0%

China Sky One Medical, Inc., a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced financial results for the fourth quarter and fiscal year ended December 31, 2009. The Company also announced its earnings guidance for full year 2010.

17 Mar 2010

Liver cancer: Treatment with intra-arterial yttrium-90 microspheres promising

An interventional radiology treatment-the use of intra-arterial yttrium-90 microspheres for liver cancer (also known as hepatocellular carcinoma)-shows promise in prolonging life for many patients with this devastating condition, according to researchers at the Society of Interventional Radiology's 35th Annual Scientific Meeting in Tampa, Fla.

17 Mar 2010

Simple common sense behaviors can help limit the spread of H1N1 in household: Study

Simple, common sense behaviors, including having a discussion at home about how to prevent influenza, can help limit the spread of H1N1 in a household, according to a study of the initial outbreak in New York City in 2009.

17 Mar 2010

Virology News and Research

Latest Virology News and Research

Influenza pandemic policies: WHO denies being improperly influenced by pharmaceutical industry

Effective defense against HIV: Acne drug minocycline

National Native HIV/AIDS Awareness Day: NIAID Director issues statement

Pressure BioSciences announces presentations on advantages of PCT

Activeion Cleaning Solutions announces new European subsidiary, Activeion GmbH

FDA categorizes Nanosphere's RVNATSP assay on Verigene SP System as "Moderate Complexity"

Researchers use optogenetics technology to troubleshoot neural circuits

Scientists synthesize multifunctional polymer that can decontaminate biological and chemical toxins

Norgen Biotek launches over 30 new kits for NA based diagnostics

Three scientists receive 2010 Discoverers Award for developing new class of HIV drug

Acne drug prevents HIV breakout

Yellow fever outbreak in howler monkeys signals the need for human vaccination program

Modulating body's inflammatory response may help fight serious infection

MediCare International offers insurance for all nationalities

Scientists discover switch mechanism that controls cells' trafficking system

CytoDyn commences full humanization of Cytolin immune therapy for treating HIV/AIDS

ICID provides online planning tools to help non-profit organizations develop pandemic flu plans

China Sky One Medical's 2009 fourth-quarter total revenues up 15.0%

Liver cancer: Treatment with intra-arterial yttrium-90 microspheres promising

Simple common sense behaviors can help limit the spread of H1N1 in household: Study

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production